XENE
$39.19
Revenue | $0Mn |
Net Profits | $-62.79Mn |
Net Profit Margins | -Inf% |
Xenon Pharmaceuticals Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2024. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated NaN% jump in its revenue since last 3-months.
Xenon Pharmaceuticals Inc’s net profit fell -29.57% since last year same period to $-62.79Mn in the Q3 2024. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated -8.4% fall in its net profits since last 3-months.
Xenon Pharmaceuticals Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2024. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.81 |
EPS Estimate Current Year | -0.81 |
Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.81 - a -15.71% fall from last quarter’s estimates.
Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.81.
Earning Per Share (EPS) | -0.81 |
Xenon Pharmaceuticals Inc’s earning per share (EPS) fell -10.96% since last year same period to -0.81 in the Q3 2024. This indicates that the Xenon Pharmaceuticals Inc has generated -10.96% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-09 | -0.66 | -0.62 | 6.06% |
2024-08-08 | -0.7 | -0.75 | -7.14% |
2024-11-12 | -0.81 | -0.81 | 0% |